News Breaks |
|
|
| January 4, 2013 |
| 11:15 EDT |  | JNJ | Janssen enters license and R&D agreements with GlycoVaxyn AG
GlycoVaxyn AG announced that Janssen Pharmaceuticals, Inc. has signed an exclusive license agreement and entered into a three-year research and development collaboration to develop a multi-valent bacterial vaccine employing GlycoVaxyn's bio-conjugation technology. GlycoVaxyn will collaborate with JPI's affiliate, Crucell Holland BV, on the development of the multi-valent vaccine until proof-of-concept, after which JPI will be responsible for later-stage clinical studies and world-wide commercialization. The consideration to GlycoVaxyn includes an upfront payment, milestone payments, royalties as well as reimbursement of research and development expenses. Financial details of the agreement have not been disclosed. Janssen Pharmaceuticals is a pharmaceutical company of Johnson & Johnson. |
|
|
News For JNJ From The Last 14 Days Check below for free stories on JNJ the last two weeks. |
|
|
| May 21, 2013 |
| 07:24 EDT |  | JNJ | Global Health Care to host a conference
 Subscribe for More Information |
|
| May 17, 2013 |
| 06:19 EDT |  | JNJ | J&J to end sales of of metal-on-metal hip replacements, Bloomberg reports
Subscribe for More Information |
|
| May 15, 2013 |
| 16:51 EDT | | JNJ | FDA approves Simponi to treat ulcerative colitis
Subscribe for More Information |
|
| May 10, 2013 |
| 11:48 EDT | | JNJ | Drugmakers to face pressure on U.S. prices, Reuters says
Subscribe for More Information |
|
| 06:16 EDT | | JNJ | Obesity surgery booming in India, Bloomberg reports
Subscribe for More Information |
|
| May 9, 2013 |
| 17:09 EDT | | JNJ | Johnson & Johnson deal to settle sales practices probe stalls, WSJ reports
Johnson & Johnson's $2.2B settlement with the Justice Department related to its promotion of certain drugs is on hold as the company is looking to avoid language in the agreement that could make it vulnerable to private lawsuits, reports The Wall Street Journal, citing people familiar with the talks. Reference Link |
|
| 09:51 EDT | | JNJ | J&J unit says first patient enrolled in reMARQable study
Subscribe for More Information |
|
| May 8, 2013 |
| 07:38 EDT | | JNJ | BofA/Merrill's medical tech analyst hold an analyst/industry conference call
Subscribe for More Information |
|
|
|
|
|
